Gavi launches new learning initiative to address final barriers to immunization equity
Addis Ababa, April 13, 2023 (FBC) – Gavi, the Vaccine Alliance (Gavi) has launched the Zero-Dose Learning Hub (ZDLH), a new mechanism to improve how data and evidence are leveraged to successfully identify and reach the millions of children who have not yet received a single routine vaccine shot – “zero-dose” children – and the missed communities in which they live.
It is noted that the goal of the ZDLH collaboration is to supplement existing and ongoing monitoring efforts by building deeper understanding and sharing learning on the complex array of factors that impact efforts to reach zero-dose children, particularly in lower-income Gavi implementing countries.
Funded and coordinated by Gavi, ZDLH is composed of Country Learning Hubs in Bangladesh, Mali, Nigeria and Uganda, as well as a global hub led by JSI Research and Training Institute, Inc. (JSI), with support from the Indian Institute of Health Management Research (IIHMR) and The Geneva Learning Foundation (TGLF).
The global hub will provide technical and operational support to countries; and disseminate learning across immunisation stakeholders at the community, national, regional and global levels.
“Zero-dose children face significant and complex systemic barriers that impact their ability to access basic services, including immunisation,” said Thabani Maphosa, Managing Director of Country Programmes Delivery at Gavi.
While incredible progress has been made in immunisation coverage, particularly in lower-income countries in the last few decades, it is clear that a percentage of children consistently miss out, with the pandemic hampering progress. The number of zero-dose children in Gavi implementing countries reduced by 14% from 2015 to 2019. However, this number increased during the pandemic; and in 2021, there were 12.5 million zero-dose children in the 57 lower-income countries supported by Gavi, the latest statement indicates.
As a result, during the 2021–2025 strategic period, Gavi and Alliance partners are focused on reaching zero-dose children and missed communities, aiming to leverage the power of innovation and new partnerships to reduce the number of zero-dose children in Gavi-eligible countries by 25% by 2025.
The ZLDH launch represents the latest initiative in this effort, alongside Gavi’s Zero-Dose Immunization Programme (ZIP), an innovative initiative that is providing two consortia of partners with up to US$ 100 million to identify and reach zero-dose children living in displaced communities and fragile and conflict settings, it is noted.
“JSI is uniquely positioned to lead the ZDLH and address the complex socio-cultural, political, geographic and economic root causes of under-immunisation. Our team will draw on years of successful implementation of innovative and finely tailored approaches to immunisation equity,” said Kate Onyejekwe, Director of JSI’s International Division. “We have convened a dynamic roster of partners to implement the ZDLH’s charge.”